Efficient transfer of proteins or nucleic acids across cellular membranes is a major problem in cell biology. Recently the existence of a fusogenic sequence was predicted in the junction area of the PreS2-and S-domain of the hepatitis-B virus surface antigens. We have identified cell permeability as a novel property of the PreS2-domain. Cell permeability of PreS2 is not restricted to hepatocytes. PreS2 translocates in an energy-independent manner into cells and is evenly distributed over the cytosol. Detailed analysis revealed that cell-permeability is mediated by an amphipatic ␣-helix between amino acids 41 and 52 of PreS2. Destruction of this translocation motif (PreS2-TLM) abolishes cell permeability. PreS2-TLM per se can act as a shuttle for peptides and functional proteins (such as EGFP). This permits the highly
Introduction
Recently a few peptide motifs have been identified conferring the unexpected property of cell permeability to proteins. These motifs are derived from the third helix of the antennapedia homeodomain (pAntp), 1 the human immunodeficiency virus (HIV) protein Tat, 2 the Kaposi fibroblast growth factor (K-FGF) 3 and the herpes simplex virus type-1 (HSV-1) structural protein VP22. 4, 5 While in the case of pAntp 16 predominantly basic amino acids, which adopt an amphipatic a-helix, mediate the cell permeability, 1 an unstructured cluster of nine amino acids is responsible for the cell permeability of the HIV-Tat protein. The cell permeability mediating domain derived from K-FGF consists of 12-16 hydrophobic amino acids. Within VP22 no clearly defined cell permeable peptide motif has been identified so far. [2] [3] [4] For none of these cell permeable proteins the translocation mechanism is completely understood but an unspecific interaction with membrane phospholipids, eventually resulting in inverted micelle formation and subsequent release of the peptides into the cytosol has been postulated. 6, 7 Based on the observation that cells non-permissive for hepatitis-B virus (HBV) infection could be infected after partial proteolytic cleavage of the viral particle, the exist- specific modulation of intracellular signal transduction by transfer of peptides competing protein-protein interactions as demonstrated by specific inhibition of TNF␣-dependent activation of c-Raf-1 kinase. Moreover in vivo functionality was demonstrated by PreS2-TLM-dependent protein transfer into primary bone marrow cells and into the liver. The amphipatic motif is conserved between the different hepatitis-B virus subtypes, and the surface proteins of avian and rodent hepadnaviruses exhibit similar amphipatic peptide sequences. In respect to hepatitis-B virus-infection, the PreS2-TLM could represent the postulated fusion peptide and play a crucial role in the internalization of the viral particle. Gene Therapy (2000) 7, 750-758.
ence of a fusogenic peptide in the PreS2-domain of the viral surface proteins has been postulated. 8, 9 HBV is the smallest human pathogenic DNA virus and belongs to the family of hepadnaviridae which infect hepatocytes with high specificity. The gene encoding for the hepatitis-B virus surface proteins consists of a single open reading frame, which is divided by three in frame AUG-start codons into the preS1-, the preS2-and the S-region. By initiation at each of the three AUG-start codons, the large (LHBs), the middle (MHBs) and the small hepatitis-B virus surface protein (SHBs) are synthesized. In addition to their role as structural proteins of the viral envelope, a transcriptional activator function has been ascribed to the PreS2 domain. Prerequisite for the activator function is the cytoplasmic orientation of the PreS2-domain, which can be observed in the case of LHBs [10] [11] [12] and of the Cterminally truncated MHBs proteins (MHBs   t   ) . 13, 14 The cytoplasmic PreS2 domain is a binding partner and activator of the protein kinase C (PKC). The activation of PKC is mediated to the nucleus via the c-Raf-1/MAP2-kinase signal transduction pathway resulting, for example, in the activation of the transcription factors AP-1 and NF-B. 15 Here we describe cell permeability as a novel and unexpected property of the PreS2 domain. The PreS2 domain harbors a short, amphipatic ␣-helical peptide, which confers cell permeability to PreS proteins and unrelated proteins when fused to it.
Results
The PreS2 domain is a cell permeable protein In order to study the cell permeability of the PreS2 domain, highly purified PreS2 protein was isolated from an eubacterial expression system as a fusion protein harboring a N-terminal hexa-his-tag and a C-terminal extension of eight amino acids derived from the S-region (Table 1) . This protein, also termed MHBs t63 , belongs to the family of PreS2 activators and exhibits transcriptional activator function. 15 For analysis of the cell permeability of the PreS2 domain HeLa (Figure 1a , b) and 293 cells (Figure 1d , e) were grown for 30 and 120 min in the presence of 2.5 m PreS2 protein in the culture medium. After extensive washing of the cells for removal of unspecifically bound protein the internalization was investigated by immunofluorescence microscopy of the fixed cells using a PreS2-specific antiserum. The immunofluorescence shows that the PreS2 protein is present in 100% of the cultured cells, demonstrating a high translocation efficiency. The internalized PreS2 protein is homogeneously distributed over the cytoplasmic compartment, while the nucleus remains unstained. There is no indication for an enrichment in subcellular structures (vesicles) involved in endocytosis.
To confirm the cytosolic localization of the PreS2 protein, cell fractionation experiments of HepG2 cells grown for 120 min in the presence or absence of PreS2 protein were performed (Figure 2 ). The cytosolic fraction was analyzed by Western blotting using a PreS2-specific antiserum. The Western blot confirms the presence of PreS2 in the cytosolic fraction.
To prove unequivocally the presence of PreS2 in the cytosolic compartment and to investigate whether the Table 1 Schematic presentation of recombinant proteins and synthetic peptides used in this study
The shaded box resembles the amphipatic ␣-helix between aa 42-51 of PreS2 or PreS2-TLM, respectively, and the sequence is given in the one letter amino acid code.
Gene Therapy membrane translocation affects its above-mentioned activator function, electrophoretic mobility shift assays (EMSA) were carried out. The activator function of PreS2 depends on its cytoplasmic localization and can be monitored by the induction of AP-1 or NF-B.
Activation of AP-1 and NF-B was determined using nuclear extracts derived from 293 cells exposed to exogenous PreS2 protein (Figure 3 ). The EMSA shows that after addition to the culture medium the PreS2 protein triggers the significant induction of AP-1 and NF-B reflecting the translocation of PreS2 into the cytoplasm.
These results indicate that (1) the PreS2 domain is a novel cell permeable protein, which (2) translocates with high efficiency (3) into the cytoplasmic compartment, and that (4) the cell permeability is not restricted to hepatocytes.
PreS2-mediated membrane translocation is a passive, energy independent process The most frequently facilitated way for proteins to enter living cells is that of receptor-mediated endocytosis. This process is energy dependent and completely abolished when the cells are incubated at 4°C. 16 To investigate whether PreS2-mediated cell permeability requires energy, we tested the translocation ability of the complete PreS1-PreS2 domain (169 amino acids in length, Table 1 that the cell permeability of the PreS1-PreS2 protein is not affected by low temperatures and confirmed the cytosolic localization. This was corroborated by indirect immunofluorescence of HepG2 cells (Figure 1g-i) showing that the entire PreS1-PreS2 domain is indeed cell permeable at 37°C, as well as at 4°C. These results demonstrate that a protein of approximately 20 kDa is transported efficiently and that translocation is a passive process, not requiring energy. This argues against classic receptormediated endocytosis.
An amphipatic ␣-helix mediates cell permeability of the PreS2-domain Having established the ability of the PreS2 domain to translocate through biological membranes, we strived to identify the motif within PreS2 responsible for cell permeability. The amphipatic character of cell permeable peptide motifs has repeatedly been described as a requirement for their ability to translocate via biological membranes. 1, 6 In the case of PreS2, previous mutagenesis studies and CD spectroscopy revealed the existence of an
Figure 2 The PreS2 domain translocates into the cytosol. Western blot analysis of HepG2 cytosolic lysates. Cells were incubated with PreS2 (2 m) at 37°C for 120 min and the lysates tested for the presence of PreS2 using a PreS2-specific primary antibody (HBV 25-19). The same results were obtained with a primary antibody directed against the Nterminal hexa-his-tag (data not shown). Similar results were obtained using 293 cells (data not shown).
amphipatic ␣-helix between amino acids 41 and 52 of the PreS2 domain (PLSSIFSRIGDP; subtype ayw). 13 Moreover, this amphipatic ␣-helix has been shown to mediate dimerization of PreS2. Replacement of three amino acid residues within the amphipatic ␣-helix by serine (PreS2-3S-mutant; PSSSSSSRIGDP; Table 1 ) resulted in a loss of the ␣-helical structure and lead to ␤-sheet conformation of the sequence of interest, thus considerably reducing the oligomerization tendency of PreS2. 13 In order to analyze the relevance of this amphipatic ␣-helical motif for the membrane translocation of PreS2, we compared the cell permeability of wtPreS2 protein and the PreS2-3S mutant into HeLa and 293 cells. The internalization of the proteins was determined by immunofluorescence microscopy ( Figure 1 ) and Western blot analysis of cellular lysate ( Figure 5 ). The immunofluorescence microscopy as well as the Western blot analysis show that cell permeability of the PreS2-3S mutant (Figure 1c , f) was drastically reduced as compared with wt-PreS2 (Figure 1b, e ). These results demonstrate that the amphipatic ␣-helix between amino acids 41 and 52 is a prerequisite for the cell permeability of the PreS2 domain. Hence it is termed PreS2-translocation-motif (PreS2-TLM or TLM) in the following.
The PreS2-TLM alone is sufficient to mediate cell permeability and allows highly specific modulation of signal transduction In order to investigate whether the PreS2-TLM is sufficient to mediate the observed cell permeability and to test the potential of PreS2-TLM to act as a carrier for other peptides we designed a synthetic fusion peptide conGene Therapy sisting of PreS2-TLM linked to a C-terminal PLAP motif derived from the cytoplasmic domain of TNF-RI (Table 1) . In a previous investigation, 17 we observed that this PLAP motif mediates the interaction of TNF-RI with the C-terminal SH3 domain of the adapter molecule Grb2. This Grb2/TNF-RI-interaction is a prerequisite for the TNF␣-dependent activation of c-Raf-1 kinase.
Figure 3 Internalized PreS2 triggers the activation of intracellular signal transduction pathways (a) EMSA using NF-kB consensus oligonucleotides in nuclear extracts of 293 cells after 60 min and 210 min incubation with PreS2 (2 m). TPA stimulated cells served as positive control unstimulated cells as negative control. Specificity of the interaction of NF-B with its consensus motif was confirmed by competition with unlabelled oligonucleotides with increasing concentration (from left to right: 5×, 10×, 25×, 50× that of

Figure 5 The cell permeability of the PreS2-domain is mediated by an amphipatic a-helix. Western blot analysis of cellular lysates of HepG2 cells after 10 min (lanes 2 and 3) and 30 min incubation (lanes 4 and 5) with PreS2 (lanes 2 and 4) or PreS2-3S-mutant (lanes 3 and 5) at concentrations of 2 m. Untreated HepG2 cells served as negative control (lane 1). Western blot analysis was carried out using a primary antibody directed against the hexa-his-tag. Identical concentrations of the PreS2 and PreS2-3S-mutant gave equivalent signals in Western blot analysis (data not shown). The same result was obtained using a PreS2-specific primary antibody (data not shown).
To determine the effect of the fusion peptide on c-Raf-1 kinase activity, HeLa cells were grown in the absence or presence of the fusion peptide and stimulated with TNF␣. The activity of c-Raf-1 kinase was determined by immunocomplex assays as described under Materials and methods. The immunocomplex assay shows that the fusion peptide abolishes the TNF␣-dependent activation of c-Raf-1 kinase ( Figure 6 ). To confirm the specificity of this effect additional controls were performed. The presence of a mutated fusion peptide harboring a KLAP motif instead of the PLAP motif did not significantly affect the TNF␣-dependent activation of c-Raf-1 kinase. The EGFdependent activation of c-Raf-1 kinase is mediated by the interaction of the middle SH2 domain of Grb2 with a phosphotyrosine residue of the EGF receptor. The EGFdependent activation of c-Raf-1 kinase was not significantly impaired by the presence of the cell permeable peptides.
These results indicate (1) that the PreS2-TLM per se is sufficient to translocate across membranes and (2) demonstrate its potential to act as a carrier for other peptides permitting a specific modulation of intracellular signal transduction. PreS2-TLM can act as a carrier for functional proteins into mammalian cell lines, primary cells and plant tissue culture In order to test the general translocation capacity of the PreS2-TLM we tested the membrane translocation of highly-purified 6H-TLM-EGFP fusion protein (27 kDa), isolated from an E. coli expression system. For control experiments a hexa-his-tagged EGFP-protein lacking the PreS2-TLM was used. The fluorescence microscopy of 293 cells incubated for 30 min with 6H-TLM-EGFP (Figure 7a ) or with 6H-EGFP (Figure 7b) shows a significant fluorescence of the intracellular compartment of the cells incubated with 6H-TLM-EGFP, whereas the cells incubated with the 6H-EGFP, which lacks the translocation motif, remain unstained. These results demonstrate that the 12 amino acid sequence PreS2-TLM per se is sufficient to confer cell permeability to a functional protein of 27 kDa in vitro.
To investigate the capacity of the novel PreS2-TLM to mediate a protein transfer into primary cells, primary mouse bone marrow cells were incubated in the presence or absence of 6H-TLM-EGFP for 60 min. The fluorescence microscopy ( Figure 7c, d) shows that 6H-TLM-EGFP translocated into different species of the primary bone marrow cells, indicating that the PreS2-TLM mediated cell permeability is not restricted to immortalized cell lines.
In view of the fact that PreS2-TLM mediated cell permeability is not targeted to certain cell types or species, we wanted to investigate whether membrane translocation resembles a general mechanism which might also occur in plant cells. For this purpose we tested the cell permeability of wtPreS2 and the PreS2-TLM-deficient mutant PreS2-3S into callus cultures of Lupinus albus. Since complete lysis of the cells required considerable dilution, hexa-his-tagged proteins were enriched by passing the lysates over a Ni-NTA-affinity column; specifically bound proteins were eluted by imidazole as described under Materials and methods. The eluates were analyzed by Western blotting using a PreS2-specific antiserum. The Western blot (Figure 7e) shows that only in case of the eluate obtained from plant cells incubated with wtPreS2, PreS2-specific proteins were detectable, whereas no specific signal was obtained in case of the cells incubated with the PreS2-3S mutant. This confirms the specificity of the observed internalization.
These results indicate that (1) the novel PreS2-TLM is able to act as a carrier for functional proteins and (2) that the carrier function is not restricted to immortalized mammalian cells.
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Figure 7 The carrier function of the PreS2-TLM is not restricted to mammalian cells. (a-e) Fluorescence microscopy of 293 cells after 30 min incubation with PreS2-TLM-EGFP (panel a) and EGFP (panel b) at concentrations of 2 m. Fluorescence microscopy of primary mouse bone marrow cells after 60 min incubation with PreS2-TLM-EGFP, 2 m (panel c) and control without exogenous protein (panel d). Western blot of affinity chromatography-concentrated lysates of lupinus albus callus cultures after 180 min incubation with PreS2 (left) or PreS2-3S (right), respectively (panel e), at concentrations of 2 m. Western blot was carried out using a PreS2-specific primary antibody (HBV25-19).
PreS2-TLM mediates cell-permeability in vivo
In the experiments described above it was observed that the PreS2-TLM is able to translocate over the plasma membrane of cultured and primary cells in vitro with very high efficiency. The resulting question was whether the PreS2-TLM also permits the in vivo transfer into intact organs. For this purpose wt-PreS2 and the PreS2-3S mutants which lack a functional PreS2-TLM, were infused into the portal vein of anesthetized rats and the livers thereafter were removed for immunohistochemical analysis using a PreS2-specific antiserum. The immunofluorescence microscopy ( Figure 8 ) of liver sections derived from rats infused with wtPreS2-protein ( Figure 8b ) shows a cytoplasmic staining of various cell types. The staining is not restricted to the endothelium cells or cells surrounding the capillaries. The wtPreS2 protein is detectable in cell layers distant from the capillaries. The staining pattern of the sections derived from rats infused with the PreS2-3S mutant (Figure 8a) shows only an unspecific fluorescence of structures also stained in livers derived from buffer-treated animals (data not shown) and of extracellular structures. These results demonstrate the functionality of the PreS2-TLM in vivo and show that the PreS2-TLM enables the internalized protein to spread from cell to cell.
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Figure 8 PreS2-TLM dependent membrane translocation in vivo. Immunofluorescence of rat liver sections after infusion of PreS2 (a) or PreS2-3S-mutant (b) at concentrations of 10 m through the portal vein in vivo. Indirect immunofluorescence was carried out using a primary antibody directed against the PreS2-domain.
Discussion
In this study we describe the identification of a novel cell permeable peptide which allows the transport of biologically active compounds across the plasma membrane into cells. To date, several members of the heterogeneous family of cell permeable proteins have been described: the third helix of the antennapedia homeodomain (pAntp), the HIV-Tat protein, the K-FGF and the HSV-1 structural protein VP22. 5, [18] [19] [20] [21] [22] [23] [24] While in the case of pAntp, an amphipatic ␣-helix of 16 amino acids mediates the cell permeability, 1 and an unstructured cluster of nine basic amino acids is responsible for the cell permeability of the HIV-1 Tat protein, 2 in case of VP22 4 and of K-FGF 3 the underlying structural motif is unknown.
The cell permeability of the PreS2-domain can be clearly ascribed to an amphipatic ␣-helical peptide at the C-terminus (aa 41-52). The novel cell permeable motif derived from the PreS2 surface antigens of HBV described in this study shares some striking features with pAntp. Both proteins are transported over biological membranes in an energy-independent manner, not involving classical endocytosis. Like pAntp, PreS2 shows a tendency to form dimers and tetramers in membrane mimetic environments and the amphipatic ␣-helix between amino acids 41 and 52 of PreS2 is involved in dimerisation. 13, 25 The PreS2-3S mutant, where the amphipatic ␣-helical structure is replaced by a ␤-sheet conformation, exhibits a reduced oligomerisation tendency 13 and no significant cell permeability.
This novel PreS2-derived translocation motif (PreS2- Kyte TLM) per se is sufficient to act as a carrier for other peptides/proteins across cellular membranes as demonstrated by the specific modulation of intracellular signal transduction pathways. The PreS2-dependent activation of AP-1 or NF-B requires the cytoplasmic localization of the PreS2-domain. 13, 14 Moreover, the specific inhibition of the TNF␣-dependent activation of c-Raf-1 kinase by a PreS2-TLM-PLAP fusion peptide competing the Grb2/TNF-RI interaction, which occurs in the cytosolic compartment, 17 confirms that the PreS2-TLM enables the translocation across the membrane. The specificity and effectiveness of these effects is demonstrated by the fact that low concentrations of 2 m protein or peptide added to the culture medium are sufficient to exhibit these intracellular effects, whereas the respective mutants fail to induce these effects.
Figure 9 Amphipatic profiles are conserved in the PreS-region of all hepadnaviruses. (a) Conservation of the amphipatic character of aa 42-51 of PreS2 in different HBV-subtypes. Schematic presentation of the distribution of hydrophilic and hydrophobic amino acids of the PreS2-TLM in the subtype ayw (1) (blue) and other subtypes ayw (2) (green), adr (1), adr (2), ayr (red) and adw and adw2 (grey). Y-axis: hydopathy-values according to
PreS2-or PreS1-PreS2 proteins are found in the cytoplasm most probably due to their interaction with cytoplasmic binding partners like hsp90 or PKC 15 (EH, unpublished results). In contrast to the cytosolic localization of translocated PreS2-and PreS1-PreS2 domains, in previous investigations we have observed an even distribution of the PreS2 domain over cytosol and nucleus when expressed in mammalian and insect cells. 13, 25 Possibly this is due to the expression of large amounts of protein in excess to the cytosolic binding partners of PreS2 and reflects the capacity of PreS2 to enter the nucleus when present in sufficient concentrations.
In contrast to the VP22-dependent translocation into the nucleus, 4 the PreS2-TLM-mediated transfer displays no preference for any subcellular structures. The fusion of PreS2-TLM to a protein harboring a nuclear localization signal results in a nucleoplasmic transport (EH, unpublished results). The complete PreS1-PreS2 protein is found in the cytoplasm. The small size of the PreS2-TLM of 12 aa, its high transfer efficiency (about 100% of the cells are affected), its low immunogenicity, the lack of any activator function of the TLM, its spreading capacity, and its defined structure function relation could make it a helpful tool for the transfer of biomolecules into cells or tissues.
In case of the antennapedia homeobox protein and the HIV-Tat protein, it has been established that their cell permeability is crucial for their biological function. This leads to the question of the physiological role of PreS2-TLM mediated cell permeability for the life cycle of HBV. MHBs is not a crucial component of the viral envelope 26 a b and it is not yet known whether the PreS2-dependent transcriptional activator function is relevant for viral replication. Within the PreS2-domain a high conservation can be observed for the PreS2-TLM between the different HBV subtypes. Within the PreS2-TLM, seven amino acids are conserved between the different subtypes and, assuming an a-helical structure as in the case of subtype ayw, a similar pattern of hydrophilic and hydrophobic patches and hence conservation of the amphipatic character can be seen (Figure 9a ). Very similar amphipatic profiles are found in the PreS domains of all investigated hepadnaviruses, although the sequence homologies are weak (Figure 9b ). Therefore we postulate, that the amphipatic character rather than the amino acid sequence itself is conserved between the different hepadnaviridae. The high degree of structural conservation of the PreS2-TLM between the hepadnaviridae suggests an essential role for the viral life cycle.
In the case of HBV, the PreS2-TLM is located in the region of the previously postulated fusion peptide, 8, 9 which becomes exposed after partial proteolytic digestion of the viral particle and seems to enable the infection of non-permissive cells by these pre-digested viral particles. We conclude that the PreS2-TLM is a good candidate for the fusion peptide and that it is exposed to the viral surface following partial proteolysis of the viral surface proteins. It is tempting to speculate that during the HBV infection, the liver cell specifically bound virus particle is cleaved by a (receptor-immanent) proteolytic activity, which results in a conformational change of the surface proteins. This could result in the exposure of the PreS2-TLM to the viral surface, permitting the internalization of the viral particle from the cell surface.
Materials and methods
Recombinant production and purification of PreS2-proteins This was carried out as described previously.
13,25
Recombinant production and purification of PreS2-TLM-EGFP fusion proteins The coding sequence for the PreS2-TLM was introduced by a forward primer upstream to the coding sequence for EGFP and amplified by PCR utilizing the plasmid pEGFP-N1 (Clontech, Palo Alto, CA, USA). The PCR product was ligated in frame to a 5′-coding sequence for a N-terminal hexa-his-tag into the vector pQe8 (Qiagen, Hilden, Germany). Recombinant production and purification was carried out as described previously, 13, 25 with the exception that sample application for affinity chromatography was carried out at pH 6.3 instead of 8.0.
Synthetic peptides
Synthesis of the peptides was performed as a step-wise solid phase peptide synthesis method and purified by C 18 reverse phase HPLC. Molecular weights of purified peptides were verified by mass spectrometry.
Cell culture and protein incubation procedure Mammalian cells (HepG2, 293, HeLa) were grown in Dulbecco's modified Eagle's medium (DMEM), 10% fetal calf serum (FCS), penicillin/streptomycin, Na-pyruvate and with the exception of immunofluorescence experiments, cells were serum deprived for 16 h before commencing the experiments. Recombinant PreS2-proteins were diluted in 5 mm Na-acetate pH 5.5 in culture medium (final pH 7.0) to final concentrations of 2 m (for Western blot and EMSA) or 2.5 m (for immunofluorescence). Recombinant PreS1-PreS2 proteins, EGFP fusion proteins and synthetic peptides were diluted in DMEM, 0.5% FCS, penicillin/streptomycin, Na-pyruvate to final concentrations of 2 m (for Western blot and EMSA or immunocomplex assays, respectively) or 2.5 m (for immunofluorescence). Incubation was carried out for the time period indicated in the results section at 37°C if not stated otherwise.
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Preparation of primary bone marrow cells The bone marrow was prepared from the femur of 4-month-old female mice. The cells were grown in DMEM, 20% FCS. Peptide incubation was performed as described above.
Cell permeability studies in callus cultures of Lupinus albus Protein incubation was carried out at 16°C at concentrations of 2 m. After 180 min incubation, cells were harvested, washed extensively and powdered under liquid nitrogen. The cell powder was immediately suspended in guanidine 6M, Tris 10 mm, Na-phosphate 100 mm, ␤-mercaptoethanol 10 mm, pH 8.0 and lysed completely by sonification. The lysate was cleared by centrifugation and the supernatant subjected to affinity chromatography on a Ni 2+ -NTA-column (Qiagen). Affinity chromatography was carried out as described in Ref. 13 and eluates tested for the presence of recombinant proteins by Western blot analysis.
In vivo protein transfer Portal vein infusion was carried out on anesthetized male rats. After introduction of a cannula into the portal vein, avoiding inhibition of the blood flow through the liver, 10 m PreS2 or PreS2-3S, respectively, were infused slowly over a period of 5 min (concentration is calculated as peptide per plasma volume passing the liver during the perfusion period of 10 min). Five minutes after termination of the peptide infusion, animals were killed, the liver removed and immediately frozen in tissue freezing medium (Jung, Berlin, Germany).
Cell fractionation and Western blot analysis
After protein incubation cells were harvested and washed five times with cold phosphate buffered saline (PBS) to remove excess protein. Cells were lysed by sonification and the lysate clarified by centrifugation. For cell fractionation the cells were lysed by homogenization using a Potter Elvjehm (Berlin, Germany) homogenisor. Unbroken cells, lysosomes and nuclei were removed by centrifugation at 10 000 g for 20 min. For preparation of pure cytosolic fraction the supernatant was centrifuged at 400 000 g for 18 min using a TLA100.2 rotor (Beckman, Fullerton, USA). The lysate/cytosolic fraction were separated by SDS-PAGE. Western blot analysis was carried out using a hexa-his-tag specific primary antibody (Qiagen) or a primary antibody directed against PreS2 (HBV 25-19, directed against amino acids 17-29 of PreS2; Q19-10 and F124, directed against the aminoterminal region of PreS2) or a PreS1-specific antibody (HBV 116). As secondary anti body, horseradish peroxidase conjugated antimouse Ig F(ab′) 2 fragment (Amersham) was used.
Electrophoretic mobility shift assays (EMSA) EMSAs were carried out using double stranded AP-1 and NF-B consensus oligonucleotides (Promega, Madison, WI, USA) which were phosphorylated using polynucleotide kinase (Promega) and ␥-32 P-ATP (Amersham-Pharmacia, Uppsala, Sweden). Preparation of nucleic extracts was carried out according to the protocol of Dignam et al. 27 0.5 ng (50 000 c.p.m./ng) radiolabelled oligonucleotide were incubated with 10 g of nuclear extracts, 2 g pdIdC, 20 g acetylated bovine serum albumin and incubated for 30 min at room temperature. Gel electro-Gene Therapy phoresis was carried out on a non-denaturing, 4% polyacrylamide gel and the dry gel exposed to an autoradiography film. As a positive control, cells were stimulated with TPA (20 ng/ml) for 15 min and treated accordingly.
Fluorescence microscopy
Following protein incubation of cells in vitro, indirect immunofluorescence was carried out after washing the cells with cold PBS three times and ethanol fixation. In the case of PreS2 and PreS2-3S-mutant incubations a primary antibody directed against PreS2 (HBV 25-19) and a Cy3-conjugated anti-mouse Fc (gamma) fragment (Jackson ImmunoResearch, West Grove, PA, USA) were used. PreS1-PreS2 was detected using a mixture of Q19-10, F124 and HBV116. Following portal vein infusion, cryocut sections of 5 m were prepared, fixed in ethanol and treated accordingly. Detection of EGFP fluorescence was carried out on unfixed cells.
c-Raf-1 kinase assay Serum-deprived HeLa cells were incubated with synthetic peptides for 2 h as described above and stimulated with 100 units/ml TNF␣ or 5 ng/ml EGF, respectively, for 15 min at 37°C. Together with the cytokines, 2 m synthetic peptides were added to avoid alteration of peptide concentrations. Activity of c-Raf-1 kinase was determined by immunocomplex assay using recombinant MEK (Santa Cruz Biotech, Santa Cruz, CA, USA) and ␥ 32 P-ATP (Amersham) as substrates. Immunocomplex assays were carried out as described in Ref. 17 .
